Avacta establishes US commercial team
Avacta Group
45.30p
16:55 24/04/24
1.80%
0.80p
Affirmer biotherapeutic and reagent developer Avacta Group announced on Monday that it has established a commercial team of three people in the US, including the appointment of Dr Matthew Vincent as vice president therapeutics business development.
FTSE AIM All-Share
754.69
16:50 24/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
21,897.50
17:09 24/04/24
0.14%
31.42